ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Total Assets : kr86.15 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Total Assets?

ExpreS2ion Biotech Holding AB's Total Assets for the quarter that ended in Mar. 2024 was kr86.15 Mil.

During the past 12 months, ExpreS2ion Biotech Holding AB's average Total Assets Growth Rate was -16.70% per year. During the past 3 years, the average Total Assets Growth Rate was 20.60% per year. During the past 5 years, the average Total Assets Growth Rate was 11.90% per year. During the past 10 years, the average Total Assets Growth Rate was 17.10% per year.

During the past 11 years, ExpreS2ion Biotech Holding AB's highest 3-Year average Total Assets Growth Rate was 66.60%. The lowest was -10.20%. And the median was 23.15%.

Total Assets is connected with ROA %. ExpreS2ion Biotech Holding AB's annualized ROA % for the quarter that ended in Mar. 2024 was -62.38%. Total Assets is also linked to Revenue through Asset Turnover. ExpreS2ion Biotech Holding AB's Asset Turnover for the quarter that ended in Mar. 2024 was 0.01.

ExpreS2ion Biotech Holding AB Total Assets Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB Total Assets Chart

ExpreS2ion Biotech Holding AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

18.71

118.86

151.96

137.36

78.69

ExpreS2ion Biotech Holding AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															103.13	115.91	101.92	78.69	86.15

ExpreS2ion Biotech Holding AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

ExpreS2ion Biotech Holding AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	65.364	+	13.328
	=	78.69

ExpreS2ion Biotech Holding AB's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	52.308	+	33.837
	=	86.15

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Total Assets Explanation

Total Assets is connected with ROA %.

ExpreS2ion Biotech Holding AB's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-51.412	/	( (78.692	+	86.145)	/ 2 )
	=	-51.412	/	82.4185
	=	-62.38 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

ExpreS2ion Biotech Holding AB's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0.923	/	( (78.692	+	86.145)	/ 2 )
=	0.923	/	82.4185
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

ExpreS2ion Biotech Holding AB Total Assets Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

5JD:Germany

Address

c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25

Website

https://www.expres2ionbio.com

ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Headlines

No Headlines